台湾为VELDONA提供阿伊诺斯专利,这是一种快速解剖的COVID-19治疗,有可能引发其他病毒性疾病。 Taiwan grants Ainos patent for VELDONA®, a rapid-dissolving COVID-19 treatment, with potential for other viral diseases.
阿诺斯公司在台湾获得了VELDONA制剂专利,这是一个创新的口服快速溶解片片,旨在治疗和预防冠状病毒感染。 Ainos has received a patent in Taiwan for its VELDONA® formulation, an innovative oral rapid-dissolving tablet aimed at treating and preventing coronavirus infections. 这一技术利用干涉增强免疫功能,并显示出防止乙型肝炎、丙型肝炎和艾滋病毒等其他病毒性疾病的希望。 This technology enhances immune function using interferon and shows promise against other viral diseases like Hepatitis B, Hepatitis C, and HIV. 该专利标志着抗病毒疗法方面的重大进步,在防治各种病毒感染方面有可能在全球得到应用。 The patent marks a significant advancement in antiviral therapies, with potential global applications in combating various viral infections.